Bausch + Lomb 

$16.49
38
-$0.19-1.14% Thursday 20:00

Statistics

Day High
16.89
Day Low
16.28
52W High
18.92
52W Low
10.45
Volume
303,164
Avg. Volume
420,068
Mkt Cap
5.84B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.07
0.07
0.21
0.36
Expected EPS
0.050237
Actual EPS
N/A

Financials

-7.06%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
10.2BRevenue
-720MNet Income

Analyst Ratings

$18.80Average Price Target
The highest estimate is 21.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLCO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the healthcare sector, offering a wide range of products including vision care products that compete directly with Bausch + Lomb's eye health products.
Novartis
NVS
Mkt Cap237.61B
Novartis, through its Alcon eye care division, provides products and equipment for eye care professionals and patients, directly competing with Bausch + Lomb's offerings.
Cooper Companies
COO
Mkt Cap13.9B
The Cooper Companies operate in the medical device sector, focusing on contact lens and women's health, making it a direct competitor in the vision care market.
Alcon
ALC
Mkt Cap36.88B
Alcon focuses on eye care products ranging from surgical devices to contact lenses, competing across several of Bausch + Lomb's key product areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, through its acquisition of Allergan, has a strong presence in the eye care market, particularly in treatments for conditions like dry eye, directly competing with Bausch + Lomb.
Staar Surgical
STAA
Mkt Cap1.28B
STAAR Surgical specializes in ophthalmic products, particularly implantable lenses, which competes with Bausch + Lomb's surgical products.
Eco Science Solutions
ESSI
Mkt Cap26,479
EssilorLuxottica is a leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, competing with Bausch + Lomb's vision care products.
Resmed
RMD
Mkt Cap36.04B
ResMed, while primarily focused on sleep apnea and respiratory conditions, also offers products in the health sector that can indirectly compete with Bausch + Lomb's broader healthcare offerings.

About

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Show more...
CEO
Mr. Brenton L. Saunders J.D.
Employees
13500
Country
CA
ISIN
CA0717051076

Listings

0 Comments

Share your thoughts

FAQ

What is Bausch + Lomb stock price today?
The current price of BLCO is $16.49 USD — it has decreased by -1.14% in the past 24 hours. Watch Bausch + Lomb stock price performance more closely on the chart.
What is Bausch + Lomb stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bausch + Lomb stocks are traded under the ticker BLCO.
Is Bausch + Lomb stock price growing?
BLCO stock has risen by +7.29% compared to the previous week, the month change is a -8.29% fall, over the last year Bausch + Lomb has showed a +26.94% increase.
What is Bausch + Lomb market cap?
Today Bausch + Lomb has the market capitalization of 5.84B
When is the next Bausch + Lomb earnings date?
Bausch + Lomb is going to release the next earnings report on May 06, 2026.
What were Bausch + Lomb earnings last quarter?
BLCO earnings for the last quarter are 0.32 USD per share, whereas the estimation was 0.36 USD resulting in a -9.9% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bausch + Lomb revenue for the last year?
Bausch + Lomb revenue for the last year amounts to 10.2B USD.
What is Bausch + Lomb net income for the last year?
BLCO net income for the last year is -720M USD.
How many employees does Bausch + Lomb have?
As of April 03, 2026, the company has 13,500 employees.
In which sector is Bausch + Lomb located?
Bausch + Lomb operates in the Health Care sector.
When did Bausch + Lomb complete a stock split?
Bausch + Lomb has not had any recent stock splits.
Where is Bausch + Lomb headquartered?
Bausch + Lomb is headquartered in Vaughan, CA.